Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.97B | 2.75B | 2.36B | 2.16B | 1.85B | 1.47B |
Gross Profit | 2.24B | 2.05B | 1.69B | 1.55B | 1.35B | 1.06B |
EBITDA | 888.74M | 730.82M | 461.96M | 488.21M | 532.94M | 407.25M |
Net Income | 809.93M | 714.14M | 525.71M | 487.71M | 427.39M | 380.00M |
Balance Sheet | ||||||
Total Assets | 8.00B | 7.34B | 5.91B | 4.80B | 3.82B | 3.05B |
Cash, Cash Equivalents and Short-Term Investments | 6.40B | 5.15B | 4.03B | 3.10B | 2.38B | 1.66B |
Total Debt | 85.45M | 75.78M | 55.77M | 60.98M | 54.59M | 63.12M |
Total Liabilities | 1.36B | 1.51B | 1.27B | 1.09B | 904.83M | 779.75M |
Stockholders Equity | 6.64B | 5.83B | 4.64B | 3.72B | 2.91B | 2.27B |
Cash Flow | ||||||
Free Cash Flow | 1.34B | 1.07B | 885.14M | 766.96M | 750.25M | 542.56M |
Operating Cash Flow | 1.35B | 1.09B | 911.34M | 780.47M | 764.46M | 551.25M |
Investing Cash Flow | -755.30M | -700.14M | -1.08B | -1.01B | -346.15M | -333.63M |
Financing Cash Flow | 169.84M | 26.11M | -16.19M | -19.38M | -4.14M | 33.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $12.99B | 59.52 | 24.25% | ― | 19.45% | 46.46% | |
79 Outperform | $44.74B | 55.99 | 13.70% | ― | 15.33% | 30.51% | |
78 Outperform | $34.58B | 15.50 | 25.60% | 0.18% | 2.30% | 41.46% | |
77 Outperform | $7.88B | 55.38 | 6.78% | ― | 15.45% | 37.72% | |
76 Outperform | $4.27B | 81.63 | 1.60% | ― | 20.60% | ― | |
65 Neutral | $13.83B | ― | -97.95% | ― | 59.84% | 76.46% | |
51 Neutral | $7.95B | -0.40 | -42.50% | 2.21% | 22.29% | -1.85% |
On August 13, 2025, Veeva Systems Inc. and IQVIA Inc. resolved all ongoing litigations that began in 2017 through a settlement agreement, which includes no damages paid by either party. The agreement also facilitates mutual access to data and software, enhancing service offerings for mutual customers. Additionally, Veeva and IQVIA announced global clinical and commercial partnerships aimed at improving efficiency and effectiveness for customers by integrating their software, data, and technology solutions. This collaboration is expected to accelerate clinical development and improve market access for treatments, benefiting shared clients and the overall industry.
On June 18, 2025, Veeva Systems held its Annual Meeting where shareholders voted on two key proposals. The first proposal involved the election of directors to serve until the 2026 annual meeting, with all nominees successfully elected. The second proposal ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending January 31, 2026.